Martin Linder

机构：Instituto Nacional de Técnica Aeroespacial, European Space Research and Technology Centre

发表论文 70 篇 · 总被引 3436 次 · h-index 17

代表论文

• A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis (2020 · New England Journal of Medicine · 被引 2001)
• Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial (2016 · Diabetes Care · 被引 342)
• Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity (2019 · Alimentary Pharmacology & Therapeutics · 被引 185)
• Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial (2020 · Diabetes Care · 被引 177)
• Mediation analysis of time‐to‐event endpoints accounting for repeatedly measured mediators subject to time‐varying confounding (2019 · Statistics in Medicine · 被引 70)
• Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers (2020 · Contemporary Clinical Trials · 被引 40)